Corporate CEOs trying to figure out how to get on President Donald Trump’s good side need look no further. David Ricks, CEO of the Indianapolis-based pharmaceutical manufacturer Eli Lilly, is putting ...

Eli Lilly & Co. is spending another $4.5 billion on its manufacturing plants in Indiana and drawing the attention of ...

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 products at ...

Drugmakers to get certainty on tariffs and access to beneficiaries who wouldn't otherwise be covered for obesity, Trump administration says Ozempic, a popular drug from Novo Nordisk used to treat ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are ...

President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the costly ...

WASHINGTON (Reuters) — U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 weight‑loss drugs for the government’s Medicare and ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...